Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of INCB054707 in Participants With Normal and Impaired Renal Function and Participants on Hemodialysis
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Incyte Corporation
Related studies linked through entity extraction aliases.
A Study to Evaluate the Pharmacokinetics and Safety of INCB054707 in Participants With Normal Hepatic Function and Participants With Hepatic Impairment
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate the Efficacy and Safety of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis Suppurativa (HS)
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Evaluate the Efficacy and Safety of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis Suppurativa
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Lichen Sclerosus
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Cutaneous Lichen Planus
- Status
- COMPLETED
- Phase
- PHASE2
Methotrexate, Tafasitamab, Lenalidomide and Rituximab in Patients With PCNSL
- Status
- RECRUITING
- Phase
- PHASE2
Study of INCA32459 a LAG-3 and PD-1 Bispecific Antibody in Participants With Select Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Expanded Access Use of Itacitinib to Treat a Single Patient With STAT1 Gain of Function (GOF) Disease
- Status
- AVAILABLE
- Phase
- N/A
Expanded Access of Axatilimab to Treat a Single Patient With Chronic Graft Versus Host Disease (GVHD)
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
Reinvigorating TNBC Response to Immunotherapy With Combination Myeloid Inhibition and Radiation
- Status
- RECRUITING
- Phase
- PHASE2
Study of Ruxolitinib Cream in Adolescents With Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE3
Chemotherapy (DA-EPOCH+/-R) and Targeted Therapy (Tafasitamab) for the Treatment of Newly-Diagnosed Philadelphia Chromosome Negative B Acute Lymphoblastic Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Combined MEK, STAT3 and PD-1 Inhibition in Metastatic Pancreatic Ductal Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE1
Study to Evaluate the Safety and Efficacy of Tafasitamab Plus Lenalidomide in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (firmMIND)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Tafasitamab Plus Lenalidomide in Relapsed CNS Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
All-Trans Retinoic Acid (ATRA) Plus PD-1 Inhibition in Recurrent IDH-Mutant Glioma
- Status
- RECRUITING
- Phase
- PHASE2
Electronic MonitorIng of Events for dIffuse Large b Cell LYmphoma
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Topical Ruxolitinib in Chronic Hand Dermatitis
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Glioblastoma or Other Primary Central Nervous System Tumors Harboring Activating FGFR1-3 Alterations
- Status
- TERMINATED
- Phase
- PHASE2